1.19 (-%)
As of Nov 21, 2024
Source:
Atossa Therapeutics, Inc is a clinical-stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology, with a current focus on breast cancer and other breast conditions.
| Country | United States |
| Headquarters | seattle, washington |
| Phone Number | 206.588.0256 |
| Industry | manufacturing |
| CEO | Steven C. Quay, M.D., Ph.D. |
| Website | www.atossatherapeutics.com |